<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31298">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02699255</url>
  </required_header>
  <id_info>
    <org_study_id>WF-01/16</org_study_id>
    <nct_id>NCT02699255</nct_id>
  </id_info>
  <brief_title>Ventricular Arrhythmias After Pulmonary Vein Isolation</brief_title>
  <official_title>A Single-center Observational Study to Examine the Occurrence of Ventricular Arrhythmias After Pulmonary Vein Isolation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <brief_summary>
    <textblock>
      Atrial fibrillation is the most common arrhythmia with a lifetime risk for development of
      over 20%. Pulmonary vein isolation is now established as therapy of choice for patients with
      symptomatic atrial fibrillation. It is well known that this interventional therapy
      inevitably modulates the intracardiac autonomic nervous system. While this ablation might
      alter atrial electrophysiology beneficially, the impact on ventricular electrophysiology
      remains unclear.

      The investigators study aimed to observe the occurrence of new premature ventricular
      complexes and other ventricular arrhythmias after pulmonary vein isolation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ventricular arrhythmias</measure>
    <time_frame>one year</time_frame>
    <description>Number of patients with premature ventricular complexes, ventricular tachycardias or ventricular fibrillation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arrhythmia recurrence</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Ventricular Arrhythmias</condition>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with paroxysmal atrial fibrillation scheduled to undergo pulmonary vein isolation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Paroxysmal atrial fibrillation scheduled to undergo pulmonary vein isolation

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Persistent atrial fibrillation

          -  Life expectancy less than 12 months

          -  Acute myocardial infarction, coronary artery bypass graft surgery, open heart
             surgery, or percutaneous transluminal coronary angioplasty within less than 3 months
             prior to inclusion

          -  Documentation of &gt;30 premature ventricular complexes per hour, salvos or ventricular
             tachycardias prior to atrial fibrillation ablation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Meyer, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology - Electrophysiology, University Heart Centre, University Hospital Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Meyer, Prof. Dr.</last_name>
    <phone>+49 40 7410 52438</phone>
    <email>chr.meyer@uke.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiology - Electrophysiology, University Heart Centre, University Hospital Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Meyer, Prof. Dr.</last_name>
      <phone>+49 40 7410 52438</phone>
      <email>chr.meyer@uke.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <lastchanged_date>February 29, 2016</lastchanged_date>
  <firstreceived_date>February 23, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Christian Meyer</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
